Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Anaptysbio Inc (NQ: ANAB )

28.35 USD -0.16 (-0.56%)
Streaming Delayed Price Updated: 11:42 AM EDT, Oct 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,940
Open 28.55
Bid (Size) 28.32 (1)
Ask (Size) 28.55 (1)
Prev. Close 28.51
Today's Range 28.00 - 28.94
52wk Range 17.72 - 35.85
Shares Outstanding 27,433,359
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AnaptysBio to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
From GlobeNewswire News Releases
FDA Grants Accelerated Approval of JEMPERLI (dostarlimab-gxly) for dMMR Recurrent or Advanced Solid Tumors
From GlobeNewswire News Releases

Performance

YTD
+21.36%
+21.36%
1 Month
+6.74%
+6.74%
3 Month
+8.83%
+8.83%
6 Month
+25.00%
+25.00%
1 Year
+10.01%
+10.01%

More News

Read More
AnaptysBio Announces Second Quarter 2021 Financial Results and Provides Pipeline Updates
From GlobeNewswire News Releases
AnaptysBio to Present at the 2021 Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
AnaptysBio Announces First Quarter 2021 Financial Results and Provides Pipeline Updates
From GlobeNewswire News Releases
European Commission Approves JEMPERLI (dostarlimab), the First Anti-PD-1 Therapy Approved for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer in Europe
From GlobeNewswire News Releases
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
From GlobeNewswire News Releases
AnaptysBio Announces Appointment of Oleg Nodelman to Board of Directors
From GlobeNewswire News Releases
AnaptysBio Reveals Updated Imsidolimab Data In Severe Form Of Psoriasis
Tags Briefs Psoriasis Phase 2 Trial
From Benzinga
AnaptysBio-Generated Antibody Scores Second FDA Approval For Solid Tumor Indication
Tags Biotech Health Care Small Cap
From Benzinga
AnaptysBio Breaks Below 200-Day Moving Average - Notable for ANAB
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.